Eprosartan Mesylate

This page contains recent news articles, when available, and an overview of Eprosartan Mesylate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Solvay to outsource Dishman's eprosartan to US  -  May 11, 2006
The company would supply 90 tonnes of eprosartan mesylate to Solvay in the ... Solvay has increased the quantity of eprosartan mesylate to be supplied by ... pharmabiz.com

Kos Enters Cardio Area, Gets Biovail Products For $104M  -  May 4, 2005
Teveten (eprosartan mesylate) was launched in 1998 by London-based ... Teveten HCT (eprosartan mesylate/hydrochlorothiazide) was launched in 2003 and ... BioWorld Online - BioWorld Online

Chemical companies eye pharma pastures  -  Jan 15, 2006
...when it signed an agreement with Netherlands-based Solvay Pharmaceuticals for sourcing eprosartan mesylate, an API for Teveten, a hypertensive drug. ... expresspharmapulse.com

Kos enters cardiovascular R&D alliance with Biovail.(Kos …  -  May 2, 2005
These include Teveten (eprosartan mesylate) and Teveten HCT (eprosartan mesylate/hydrochlorothiazide), as well as exclusive rights to sell Cardizem LA ... $4.95 - Pharma Marketletter - ECNext

INDIA'S DISHMAN COMPLETES USFDA INSPECTION FOR …  -  May 8, 2006
The facility, a 100 per cent Export Oriented Unit, manufactures 'Eprosartan Mesylate', which would be supplied to global major Solvay Pharmaceuticals, BV, ... $4.95 - AsiaPulse News - ECNext

Kos Reports 49% Increase in Revenue to $179.4 Million, Earnings Per …  -  Aug 4, 2005
In May 2005, the Company acquired from Biovail Corporation's affiliates an exclusive license to Teveten (eprosartan mesylate) and Teveten HCT (eprosartan ... $4.95 - Business Wire - ECNext

Bombay Stocks Edge Higher  -  May 5, 2006
The company has completed US FDA inspection for one of its facility to make Eprosartan Mesylate, an anti hyper-tension drug, to be supplied to Solvay ... TheStreet.com - TheStreet.com (subscription)

Federal Register 2008 - 73 FR 51829 Publication of Guidances for …  -  Sep 5, 2008
...multiple RLDs) (24) Divalproex Sodium (25) Doxycycline (multiple dosage forms) (26) Eprosartan Mesylate; Hydrochlorothiazide (27) Esterified Estrogens ... Pay-Per-View - Federal Register 2008 - Loislaw

Dishman to buy Solvay fine chemicals unit  -  Jul 9, 2007
Dishman currently supplies the API for Eprosartan Mesylate (EM) - a hypertensive drug marketed by Solvay under the brand Teveten - and its intermediates, ... In-PharmaTechnologist.com

Consolidation gains  -  Jun 8, 2007
It will manufacture Eprosartan Mesylate (API) for being supplied to Solvay and the annual capacity would go up from 60 tonnes to 200 tonnes, adding further ... Daily News & Analysis

Fenofibrate is Solvay Pharmaceuticals Flagship Product and Principal ...  -  Jan 12, 2007
...(dronabinol) and Serc (betahistine); the influenza vaccine, Influvac; the pancreatic enzyme, Creon; and Teveten (eprosartan mesylate) for hypertension. ... Free with registration - M2 Presswire - AccessMyLibrary.com

Indian Pharma turns spotlight on R&D: FICCI  -  Sep 8, 2005
Dishman Pharmaceuticals' deal with Solvay Pharmaceuticals for supplying eprosartan mesylate, IPCA Labs deal with Merck for bulk drugs and with Tillomed ... pharmabiz.com

Angiotensin II receptor blockers (ARBs) for high blood pressure  -  Apr 24, 2007
...side effects (such as a cough) associated with ACE inhibitors. 1. Eprosartan mesylate (Teveten) is a recently approved ARB that is combined with a diuretic. MSN Health & Fitness

Dishman successfully completes US FDA inspection  -  May 5, 2006
...to manufacture Eprosartan Mesylate, an anti hyper-tension drug, to be supplied to Solvay Pharmaceuticals, BV, a fortune 500 company. ... Moneycontrol.com

BRIEFING - ASIA HEALTH - MAY 8, 2006.  -  May 8, 2006
The facility, a 100 per cent Export Oriented Unit, manufactures 'Eprosartan Mesylate', which would be supplied to global major Solvay Pharmaceuticals, BV, ... Free with registration - AsiaPulse News - AccessMyLibrary.com

Press Release: Fenofibrate is Solvay Pharmaceuticals Flagship Product...  -  Jan 12, 2007
...(dronabinol) and Serc (betahistine); the influenza vaccine, Influvac; the pancreatic enzyme, Creon; and Teveten (eprosartan mesylate) for hypertension. ... Pay-Per-View - M2 Presswire - HighBeam Research

Rising players in global fine chemicals: Select large custom …  -  Jul 1, 2006
In May, the Bavla facility successfully completed an FDA inspection for manufacturing the antihypertensive drug eprosartan mesylate for Solvay ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Mar 11, 2006
Teveten (Eprosartan Mesylate). Angiotensin II Receptor Antagonists/Thiazide Diuretic Agents. Therapeutics that treat high blood pressure by blocking the ... $250.00 - Revere Reports - Revere

Company Profile Report  -  Dec 16, 2006
Teveten (Eprosartan Mesylate). Angiotensin II Receptor Antagonists/Thiazide Diuretic Agents. Products:. Teveten HCT (Eprosartan/Hydrochlorothiazide) ... $50.00 - Revere Reports - Revere

Drug/Medical Device  -  Dec 16, 2006
Teveten (Eprosartan Mesylate), Hypertension, Upper Respiratory Tract Infections, Rhinitis, Pharyngitis, Cough, Fatigue, Viral Infections, Abdominal Pain ... $70.00 - Revere Reports - Revere





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy